Evidence map›Paper›PMID 39074069›Full record

ArticleJCI insight2024

Connexin-45 is expressed in mouse lymphatic endothelium and required for lymphatic valve function.

Michael J Davis, Jorge A Castorena-Gonzalez, Min Li, Scott D Zawieja, Alex M Simon, Xin Geng, R Sathish Srinivasan

Abstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Guidelines for evaluating endothelial function in vascular tissue.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Developmental progression of lymphatic valve morphology and function.Frontiers in cell and developmental biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael J DavisDepartment of Medical Pharmacology & Physiology, University of Missouri, Columbia, Missouri, USA.
Jorge A Castorena-GonzalezDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Min LiDepartment of Medical Pharmacology & Physiology, University of Missouri, Columbia, Missouri, USA.
Scott D ZawiejaDepartment of Medical Pharmacology & Physiology, University of Missouri, Columbia, Missouri, USA.
Alex M SimonDepartment of Physiology, University of Arizona School of Medicine, Tucson, Arizona, USA.
Xin GengCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
R Sathish SrinivasanCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.

Funding

Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and DiseaseR01HL133216 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI CHEN, HONG, DIXON, JAMES BRANDON · 2016 to 2025
$6.7M
Lymphatic pacemaking and pumping in lymphedema: function, dysfunction, and rescueR01HL122578 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI DAVIS, MICHAEL JOHN · 2015 to 2023
$4.1M
Defining the Mechanisms of Lymphatic Vascular Growth and FunctionR01HL131652 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI SRINIVASAN, RAJANARAYANAN S · 2016 to 2025
$3.9M
Novel lymphatic genes that regulate heart valve development and diseaseR01HL163095 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Rajanarayanan S Srinivasan · 2023 to 2026
$2.2M
Trpv4 regulation of lymphatic vascular function: Implications in metabolic syndromeR01HL168568 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI Jorge Augusto Castorena · 2023 to 2026
$1.9M
Endothelial dependent mechanisms of lymphatic dysfunction in metabolic syndrome and type-2 diabetes associated with obesityR00HL141143 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI CASTORENA, JORGE AUGUSTO · 2020 to 2022
$746k
NHLBI NIH HHS R00 HL141143NHLBI NIH HHS R01 HL122578NHLBI NIH HHS R01 HL131652NHLBI NIH HHS R01 HL133216NHLBI NIH HHS R01 HL163095NHLBI NIH HHS R01 HL168568
6 · The paper itself

Abstract

The expression and functional relevance of the gap junction molecule connexin-45 (Cx45; GJC1) in lymphatic endothelium were not previously known. We found that Cx45 was expressed widely in the endothelium of murine lymphatics, in both valve and nonvalve regions. Cell-specific deletion of Cx45, driven by a constitutive Cre line (Lyve1-Cre) or an inducible Cre line (Prox1-CreERT2), compromised the function of lymphatic valves, as assessed by physiological tests (back leak and closure) of isolated, single-valve vessel segments. The defects were comparable to those previously reported for loss of Cx43, and as with Cx43, deletion of Cx45 resulted in shortening or increased asymmetry of lymphatic valve leaflets, providing an explanation for the compromised valve function. In contrast with Cx43, lymphatic endothelial cell-specific (LEC-specific) deletion of Cx45 did not alter the number of valves in mesenteric or dermal lymphatic networks or the expression patterns of the canonical valve-associated proteins PROX1, ITGA9, or CLAUDIN5. Constitutive deletion of Cx45 from LECs resulted in increased backflow of injected tracer in popliteal networks in vivo and compromised the integrity of the LEC permeability barrier in a subset of collecting vessels. These findings provide evidence for an unexpected role of Cx45 in the development and maintenance of lymphatic valves.

Indexed as

ConnexinsEndothelial CellsEndothelium, LymphaticLymphatic VesselsAnimalsFemaleMaleMiceMice, Knockoutconnexin 45ConnexinsCell biologyEmbryonic developmentLymphVascular biology

Identifiers

PMID39074069
PMCPMC11343601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.